The US National Institutes of Health mentioned on Wednesday it had begun a mid-stage study to identify the threat of allergic reactions to COVID-19 vaccines created by Moderna Inc and Pfizer Inc.
Several allergic reaction incidents, like really serious episodes, identified as anaphylaxis, have been reported in the US right after vaccinations of Pfizer/BioNTech and Moderna shots.
In January, the US Centers for Disease Control and Prevention mentioned allergic reactions are occurring at a price of 11.1 per 1 million vaccinations.
The study, funded by the National Institute of Allergy and Infectious Diseases, will enroll 3,400 adults in between the ages of 18 to 69, with about 60% participants possessing a history of extreme allergic reactions to meals, insect stings or immunotherapy.
The target of the trial is to access the proportion of participants who have a systemic allergic reaction inside 90 minutes right after injection.
The agency expects to report information later this summer time.
(This story has not been edited by TheSpuzz employees and is auto-generated from a syndicated feed.)